miR26a knockdown embryos have increased endothelial pSmad1.
A-D) Ventral view confocal projections of the 4 dpf ventral aorta (dotted outline). Endothelial nuclei (fli1a:nEGFP; A-D, arrowheads) and pSmad1/5/9 (pSmad1,white A’- D’) and overlay (magenta, A”- D”) in 4 dpf Scr. Control (A), miR26a MO (B), dCas9 control (C) and miR26a CRISPRi (D) embryos. Yellow arrowheads indicate double positive pSmad1 + fli1a:nEGFP nuclei in the ventral aorta. E) Quantification of total number of fli1a:nEGFP nuclei in the ventral aorta. F-G) Quantification of the percentage of double pSmad1; fli1a:nEGFP positive nuclei in miR26a morphants (F) and miR26a CRISPRi (G) embryos. N = 3 experiments. Total embryos are as follows: Scr. Control MO n = 14, miR26a MO n = 14, dCas9 control n = 9 and miR26a CRISPRi n = 10. Student's two-tailed t-test, p***< 0.0001 and p ****< 0.00001 as compared to WT, error bars = SD. Scale bar: represents 50μm.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ PLoS Genet.
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if
additional information is required.
Oops. Something went wrong. Please try again later.